Biokin to Present at J.P. Morgan's 44th Annual Healthcare Conference
PR Newswire —
REDMOND, Wash., Jan. 13, 2026 /PRNewswire/ -- SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, today announced that its affiliate, Sichuan Biokin Pharmaceutical Co., Ltd. (Biokin) will present at the J.P. Morgan's 44th Annual Healthcare Conference on Thursday, January...